Ad is loading...
NSDVX
Price
$23.45
Change
-$0.07 (-0.30%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

NSDVX vs VISVX

Header iconNSDVX vs VISVX Comparison
Open Charts NSDVX vs VISVXBanner chart's image
North Star Dividend I
Price$23.45
Change-$0.07 (-0.30%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
NSDVX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NSDVX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NSDVX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. NSDVX (94.2M). VISVX pays higher dividends than NSDVX: VISVX (1.90) vs NSDVX (1.73). NSDVX was incepted earlier than VISVX: NSDVX (11 years) vs VISVX (27 years). NSDVX is a more actively managed with annual turnover of: 23.00 vs. VISVX (16.00). VISVX has a lower initial minimum investment than NSDVX: VISVX (3000) vs NSDVX (5000). VISVX annual gain was more profitable for investors over the last year : 28.71 vs. NSDVX (18.87). VISVX return over 5 years is better than : 57.32 vs. NSDVX (28.23).
NSDVXVISVXNSDVX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years27 years-
Gain YTD9.38515.43361%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets94.2M57.6B0%
Annual Yield % from dividends1.731.9091%
Returns for 1 year18.8728.7166%
Returns for 3 years0.0413.230%
Returns for 5 years28.2357.3249%
Returns for 10 years51.65108.2148%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics